ESIH:XETRA:XETRA-

| Sector Equity Healthcare |

Last Closing

USD 7.064

Change

-0.09 (-1.22)%

Market Cap

USD 0.60B

Volume

0.23M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for Sector Equity Healthcare

Symbol Name Price(Change) Market Cap
QDVG:XETRA

-0.04 (-0.38%)

USD 2.05B
2B78:XETRA

-0.06 (-0.77%)

USD 1.14B
XUHC:XETRA

-0.17 (-0.30%)

USD 0.85B
LYPE:XETRA

-2.10 (-0.42%)

USD 0.78B
LHTC:XETRA

-1.16 (-0.76%)

USD 0.73B
EXV4:XETRA

-0.60 (-0.51%)

USD 0.70B
SPYH:XETRA

-1.40 (-0.62%)

USD 0.66B
2B77:XETRA

-0.04 (-0.57%)

USD 0.50B
ZPDH:XETRA

-0.14 (-0.32%)

USD 0.40B
DXSE:XETRA

-1.40 (-0.60%)

USD 0.14B

ETFs Containing ESIH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity Healthcare) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.11% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.11% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 8.23% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.23% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.27% 45% F 47% F
Dividend Return 5.27% 44% F 44% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.62% 80% B- 84% B
Risk Adjusted Return 79.67% 69% C- 73% C
Market Capitalization 0.60B N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.